Cargando…

Sex differences in COVID-19 mortality in the Netherlands

INTRODUCTION: Since the first reports of COVID-19 cases, sex-discrepancies have been reported in COVID-19 mortality. We provide a detailed description of these sex differences in relation to age and comorbidities among notified cases as well as in relation to age and sex-specific mortality in the ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niessen, Annabel, Teirlinck, Anne C., McDonald, Scott A., van der Hoek, Wim, van Gageldonk-Lafeber, Rianne, Knol, Mirjam J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151564/ https://www.ncbi.nlm.nih.gov/pubmed/35138581 http://dx.doi.org/10.1007/s15010-021-01744-0

Ejemplares similares

Mortality surveillance in the Netherlands: severity of winter 2016/2017
por: van Asten, Liselotte, et al.
Publicado: (2018)

General practitioners' contribution to the management of community-acquired pneumonia in the Netherlands: a retrospective analysis of primary care, hospital, and national mortality databases with individual data linkage
por: Snijders, Bianca EP, et al.
Publicado: (2013)

Inference of age‐dependent case‐fatality ratios for seasonal influenza virus subtypes A(H3N2) and A(H1N1)pdm09 and B lineages using data from the Netherlands
por: McDonald, Scott A., et al.
Publicado: (2023)

Mortality surveillance in the Netherlands: winter 2015/2016 of moderate severity
por: van Asten, Liselotte, et al.
Publicado: (2017)

Experience of establishing severe acute respiratory surveillance in the Netherlands: Evaluation and challenges
por: Marbus, S.D., et al.
Publicado: (2020)

Excess Deaths during Influenza and Coronavirus Disease and Infection-Fatality Rate for Severe Acute Respiratory Syndrome Coronavirus 2, the Netherlands
por: van Asten, Liselotte, et al.
Publicado: (2021)

Mortality Monitoring in the Netherlands
por: van Asten, Liselotte, et al.
Publicado: (2014)

Targeted Screening for Chronic Q Fever, the Netherlands
por: Reukers, Daphne F.M., et al.
Publicado: (2022)

An evidence synthesis approach to estimating the incidence of seasonal influenza in the Netherlands
por: McDonald, Scott A, et al.
Publicado: (2014)

Incidence and costs of hospitalized adult influenza patients in The Netherlands: a retrospective observational study
por: Marbus, Sierk D., et al.
Publicado: (2020)

Case-based reported mortality associated with laboratory-confirmed influenza A(H1N1) 2009 virus infection in the Netherlands: the 2009-2010 pandemic season versus the 2010-2011 influenza season
por: van Gageldonk-Lafeber, Rianne AB, et al.
Publicado: (2011)

The impact of national vaccination policy changes on influenza incidence in the Netherlands
por: McDonald, Scott A., et al.
Publicado: (2016)

The relative clinical impact of 2009 pandemic influenza A (H1N1) in the community compared to seasonal influenza in the Netherlands was most marked among 5–14 year olds
por: van Gageldonk‐Lafeber, Arianne B., et al.
Publicado: (2011)

Livestock-associated risk factors for pneumonia in an area of intensive animal farming in the Netherlands
por: Freidl, Gudrun S., et al.
Publicado: (2017)

The estimated disease burden of acute COVID-19 in the Netherlands in 2020, in disability-adjusted life-years
por: McDonald, Scott A., et al.
Publicado: (2022)

Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015
por: Wagenvoort, Gertjan H J, et al.
Publicado: (2017)

Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands
por: Thorrington, Dominic, et al.
Publicado: (2018)

Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022
por: Eggink, Dirk, et al.
Publicado: (2022)

The incidence of symptomatic infection with influenza virus in the Netherlands 2011/2012 through 2016/2017, estimated using Bayesian evidence synthesis
por: Teirlinck, A. C., et al.
Publicado: (2018)

Testing behaviour and positivity for SARS-CoV-2 infection: insights from web-based participatory surveillance in the Netherlands
por: McDonald, Scott A, et al.
Publicado: (2021)

Characteristics of Hospitalized Acute Q Fever Patients during a Large Epidemic, The Netherlands
por: Wielders, Cornelia C. H., et al.
Publicado: (2014)

Hepatitis E virus seroprevalence among the general population in a livestock-dense area in the Netherlands: a cross-sectional population-based serological survey
por: van Gageldonk-Lafeber, Arianne B., et al.
Publicado: (2017)

Identified micro-organisms in hospitalized community-acquired pneumonia patients living near goat and poultry farms
por: Roof, Inge, et al.
Publicado: (2021)

Risk factors for acute respiratory tract infections in general practitioner patients in The Netherlands: a case-control study
por: van Gageldonk-Lafeber, Arianne B, et al.
Publicado: (2007)

No evidence of Legionella infection in general practice patients presenting with acute respiratory infections in The Netherlands
por: Diederen, B. M. W., et al.
Publicado: (2005)

ARI-EL: case-controleonderzoek naar Acute Respiratoire Infecties in de Eerste Lijn
por: Bartelds, Aad, et al.
Publicado: (2006)

Media Reports as a Source for Monitoring Impact of Influenza on Hospital Care: Qualitative Content Analysis
por: Reukers, Daphne F M, et al.
Publicado: (2020)

Space-time analysis of pneumonia hospitalisations in the Netherlands
por: Benincà, Elisa, et al.
Publicado: (2017)

Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021
por: de Gier, Brechje, et al.
Publicado: (2021)

Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021
por: de Gier, Brechje, et al.
Publicado: (2021)

Incidence and severity of SARS-CoV-2 infection in former Q fever patients as compared to the Dutch population, 2020–2021
por: den Boogert, Elisabeth Maria, et al.
Publicado: (2022)

Sex differences in temperature-related all-cause mortality in the Netherlands
por: Folkerts, Mireille A., et al.
Publicado: (2021)

Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022
por: van Iersel, Senna C.J.L., et al.
Publicado: (2023)

An evidence synthesis approach to estimating the incidence of symptomatic pertussis infection in the Netherlands, 2005–2011
por: McDonald, Scott A., et al.
Publicado: (2015)

Rapid assessment of regional SARS-CoV-2 community transmission through a convenience sample of healthcare workers, the Netherlands, March 2020
por: Reusken, Chantal B, et al.
Publicado: (2020)

High Infection Secondary Attack Rates of Severe Acute Respiratory Syndrome Coronavirus 2 in Dutch Households Revealed by Dense Sampling
por: Reukers, Daphne F M, et al.
Publicado: (2021)

The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands
por: McDonald, Scott A, et al.
Publicado: (2012)

Occurrence and Nature of Double Alleles in Variable-Number Tandem-Repeat Patterns of More than 8,000 Mycobacterium tuberculosis Complex Isolates in The Netherlands
por: Jajou, Rana, et al.
Publicado: (2018)

Utility of the first few100 approach during the 2009 influenza A(H1N1) pandemic in the Netherlands
por: van Gageldonk-Lafeber, Arianne B, et al.
Publicado: (2012)

Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022
por: de Gier, Brechje, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_prf9cugg6bv7hq9g0uck2s92bh